Fig. 12. Schematic representation of a multifunctional IDCB–LDH nanomedicine. (a) The hybrid nanomedicine is constructed by first coating with BSA and then orderly loading ICG, DOX/DNA prodrug, and CPG ODN 1826. (b) IDCB–LDH with 808 nm NIR irradiation heats the tumor tissues and releases DOX at a temperature above 41 °C to kill tumor cells through efficient PTT. (c) Mature DCs activate naïve T cells in dLNs and induce potent CTLs. Reproduced with permission from ref. 135. Copyright 2019, American Chemical Society.
